Metolazone Tablet
Product Images NDC 50742-349

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Metolazone (NDC 50742-349). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (1e566c10 4498 4f79 8874 4cc8c4216213 1)

FDA Label Image

Metolazone Tablets (2.5 mg -100's)

Metolazone Tablets (2.5 mg -100's)
This is a medication containing Metolazone in a tablet form with dosage information found in prescribing information. It is important not to substitute with other formulations equivalent to Mykrox or Zaroxolyn. The tablets should be stored at a controlled room temperature and protected from light. This medication is intended for adult use only and should be kept out of the reach of children. Manufactured for Ingenus Pharmaceuticals in India. No information is available in the overprinting zone.*
FDA Label Image

Metolazone Tablets (5 mg -100's)

Metolazone Tablets (5 mg -100's)
Metolazone, USP 5mg tablets manufactured by Ingenus Pharmaceuticals, LLC. Each tablet contains 5mg of Metolazone. These tablets are not to be substituted with formulations equivalent to Metolazone tablets, Zaroxolyn, and Mykrox. The proper dosage can be found in the prescribing information. Store at 25°C with allowable temperatures between 15°-30°C. Protect from light and keep out of the reach of children. The Neutral Code is DRUGS/AP/01/2006 and product code is NDC 50742-350-01.*
FDA Label Image

Metolazone Tablets (2.5 mg -100's)

Metolazone Tablets (2.5 mg -100's)
Each tablet contains 10 mg of Metolazone, USP. This medication should not be substituted with formulations equivalent to metolazone tablets, USP, or to Zaroxolyn®, and formulations equivalent to Mykrox®. Dosage instructions can be found in the prescribing information. The tablets should be stored at 25°C (77°F) and kept away from light. This medication should be kept out of reach of children. The neutral code for this drug is DRUGS/AP/01/2006 and the NDC number is 50742-351-01. The tablets are manufactured by Ingenus Pharmaceuticals, LLC in India.*
FDA Label Image

Ingenus Logo (1e566c10 4498 4f79 8874 4cc8c4216213 5)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.